Extracellular ATP is a potent signaling molecule that regulates different biological activities including proliferation, differentiation as well as cell death. Several studies have implicated extracellular ATP as a mitogenic agent in various cells in vitro. Herein, we aimed to investigate the involvement of ATP in mitogenic processes in vivo via stimulation of P2X7Rs in rat kidney. Results from the current study showed that administration of ATP caused rapid activation of ADAM-17 with subsequent phosphorylation of EGFR and ERK-1/2. Cyclin B1 expression in rat kidney was also increased following ATP administration. Interestingly, a marked decrease in renal ADAM-17 levels as well as EGFR and ERK-1/2 phosphorylation was noticed when the animals were pretreated with the purinergic P2X7R antagonist, A 438079 before ATP administration. Moreover, ATP administration significantly increased serum levels of NO, an effect that was significantly ameliorated by A 438079 pretreatment. Collectively, current findings demonstrate the ability of ATP to activate the ADAM-17-mediated EGFR/ERK-1/2 phosphorylation and to enhance the expression of the cell proliferation gene cyclin B1, an effect that is largely mediated via P2X7Rs and involves NO modulation. Thus, the safety of ATP supplementation as an ergogenic aid for muscle building and performance enhancement should be reassessed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.